Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.

@article{Pierre2005ExtrapyramidalSW,
  title={Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.},
  author={Joseph M. Pierre},
  journal={Drug safety},
  year={2005},
  volume={28 3},
  pages={
          191-208
        }
}
The treatment of schizophrenia changed drastically with the discovery of antipsychotic medications in the 1950s, the release of clozapine in the US in 1989 and the subsequent development of the atypical or novel antipsychotics. These newer medications differ from their conventional counterparts, primarily based on their reduced risk of extrapyramidal symptoms (EPS). EPS can be categorised as acute (dystonia, akathisia and parkinsonism) and tardive (tardive dyskinesia and tardive dystonia… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 62 extracted citations

Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009).

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists • 2017
View 5 Excerpts
Highly Influenced

A Retrospective Study of Long Acting Risperidone Use to Support Treatment Adherence in Youth with Conduct Disorder

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology • 2017

Similar Papers

Loading similar papers…